Article

Suppressing mortality and curbing cellular damage by targeting VHL

medRxiv · 2024 · Jiang, W.; Cao, Y.; Xue, Y.; Ji, Y.; Winer, B. Y.; Zhang, M.; Singhal, N. S.; Pierce, J.; Chen, S.; Ma, D. K.

Key facts

Title Suppressing mortality and curbing cellular damage by targeting VHL
First author Jiang, W.; Cao, Y.; Xue, Y.; Ji, Y.; Winer, B. Y.; Zhang, M.; Singhal, N. S.; Pierce, J.; Chen, S.; Ma, D. K.
Journal medRxiv
Published Jan 1, 2024
DOI 10.1101/2024.02.28.582664
Devices mentioned BK110039, DEN000008, K022086, K103302, K202641, K231013, K973350, K990827
Product codes mentioned JCI, JJH, KIP, KIT, NDS, NJT, OOI, JLX, KQP, PCA, QBD

At a glance

  • 1–9 FDA submissions mentioned
  • 10–99 Product codes mentioned

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Literature

Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.

Source: Publisher and PubMed metadata; device mentions identified by Orca1

Browse all Literature